BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25452756)

  • 21. Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan.
    Kobayashi S; Fujimoto S; Takahashi K; Suzuki K
    Kidney Blood Press Res; 2010; 33(6):442-55. PubMed ID: 21071954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variants in ANCA-associated vasculitis: a meta-analysis.
    Rahmattulla C; Mooyaart AL; van Hooven D; Schoones JW; Bruijn JA; Dekkers OM; ; Bajema IM
    Ann Rheum Dis; 2016 Sep; 75(9):1687-92. PubMed ID: 26443607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond.
    Paroli M; Gioia C; Accapezzato D
    Antibodies (Basel); 2023 Mar; 12(1):. PubMed ID: 36975372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group.
    Humbert S; Guilpain P; Puéchal X; Terrier B; Rivière S; Mahr A; Pagnoux C; Bagnères D; Cordier JF; Le Quellec A; Altwegg R; Guillevin L;
    Rheumatology (Oxford); 2015 Nov; 54(11):1970-5. PubMed ID: 26106214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [ANCA-associated forms of vasculitis].
    Helmchen U; Kneissler U; Prall F
    Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Churg-Strauss syndrome.
    Keogh KA; Specks U
    Semin Respir Crit Care Med; 2006 Apr; 27(2):148-57. PubMed ID: 16612766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship among antineutrophil cytoplasmic antibody, blood urea nitrogen and complement in patients with eosinophilic granulomatosis polyangiitis (Churg-Strauss syndrome).
    Kawakami T; Kimura S; Takeuchi S; Soma Y
    J Dermatol; 2013 Jul; 40(7):511-5. PubMed ID: 23594281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of cutaneous vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a case series.
    Ishibashi M; Kawahara Y; Chen KR
    Am J Dermatopathol; 2015 Mar; 37(3):214-21. PubMed ID: 25079200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of ANCA-associated vasculitides: HLA and beyond.
    Alberici F; Martorana D; Bonatti F; Gioffredi A; Lyons PA; Vaglio A
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S90-7. PubMed ID: 24854378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological drugs in ANCA-associated vasculitis.
    Lutalo PM; D'Cruz DP
    Int Immunopharmacol; 2015 Aug; 27(2):209-12. PubMed ID: 25907243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal vasculitis in Japan and the UK--are there differences in epidemiology and clinical phenotype?
    Watts RA; Scott DG; Jayne DR; Ito-Ihara T; Muso E; Fujimoto S; Harabuchi Y; Kobayashi S; Suzuki K; Hashimoto H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3928-31. PubMed ID: 18565978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss Syndrome) with microscopic eosinophilic thromboembolism and cardiac involvement: report of two cases.
    Isawa Y; Osada S; Omi T; Kawana S
    Eur J Dermatol; 2013; 23(5):677-80. PubMed ID: 24153238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.
    Cartin-Ceba R; Fervenza FC; Specks U
    Curr Opin Rheumatol; 2012 Jan; 24(1):15-23. PubMed ID: 22089095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurological involvement in Wegener's granulomatosis].
    Asakura K; Muto T
    Brain Nerve; 2013 Nov; 65(11):1311-7. PubMed ID: 24200609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.
    Mahr A; Katsahian S; Varet H; Guillevin L; Hagen EC; Höglund P; Merkel PA; Pagnoux C; Rasmussen N; Westman K; Jayne DR;
    Ann Rheum Dis; 2013 Jun; 72(6):1003-10. PubMed ID: 22962314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy.
    Novikov P; Kozlovskaya N; Moiseev S; Shilov E; Bobkova I; Schreiber A; Tsvetkov D; Gollasch M; Mah N; El Amrani K; Kurtz A
    Biomed Hub; 2016; 1(3):1-11. PubMed ID: 31988889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microscopic polyangiitis (microscopic polyarteritis).
    Jennette JC; Thomas DB; Falk RJ
    Semin Diagn Pathol; 2001 Feb; 18(1):3-13. PubMed ID: 11296991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antineutrophil cytoplasmic antibody-associated vasculitis in Taiwan: A hospital-based study with reference to the population-based National Health Insurance database.
    Wu CS; Hsieh CJ; Peng YS; Chang TH; Wu ZY
    J Microbiol Immunol Infect; 2015 Oct; 48(5):477-82. PubMed ID: 24560699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antineutrophil cytoplasmic antibody(ANCA)].
    Yoshida M
    Rinsho Byori; 2003 Jul; 51(7):644-8. PubMed ID: 12924248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.